돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 411613생성일: 2026년 10월 25일

Lansoprazole → 1-(pyridine-3-sulfonyl)-2-[(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methylsulfinyl]-1H-benzimidazole

https://huagongshe.com/reaction/411613

반응식

참여 물질

역할이름HCID투입량
반응물LansoprazoleHCID 3883—
반응물Pyridine-3-sulfonyl chlorideHCID 3164136—
용매DichloromethaneHCID 6344—
용매TriethylamineHCID 8471—
생성물1-(pyridine-3-sulfonyl)-2-[(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methylsulfinyl]-1H-benzimidazoleHCID 1031143568%

반응 단계

2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole (370 mg) was dissolved in 20 ml of dichloromethane and 1 ml of triethylamine. Pyridine-3-sulfonyl chloride (195 mg) was added and stirred in ice-bath for 5 hr. Dichloromethane layer was washed with an aqueous solution composed of 0.1M NaCl and 0.1M sodium bicarbonate. Dichloromethane layer was dried over anhydrous magnesium sulfate. Solvent was removed under reduced pressure. Residual material was precipitated by dichloromethane-ethyl ether-heptane to provide 348 mg of 1-(pyridine-3-sulfonyl)-2-[(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methylsulfinyl]-1H-benzimidazole.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06559167B1
출처 데이터셋uspto-grants-2003_05
ORD IDord-59ee65c6d6894c7082c058d4936d9574
출처 메모uspto-grants-2003_05